Appistry, PGDx Sign Deal for Cancer Panel | GenomeWeb

NEW YORK (GenomeWeb) – Appistry said today that it has signed a deal to include Personal Genome Diagnostics' CancerSelect panel in the recently released Appistry CloudDx genomics testing service.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: transcriptional and translational study of human cytomegalovirus interactions with host cells, spider web DNA study, and more.

The New York Stem Cell Foundation signs a lease for a new space.

Researchers gear up for an international meeting to discuss the ethics of gene editing.

In Nucleic Acids Research this week: personal genome approach to RNA-seq read alignment, hematopoietic Systems Biology Repository, and more.